Drug recall · July 19, 2017
EliquisTablets 5mg recall
Why: Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21
- Lots / codes
Lot: HN0063, EXP. 09/2019
- Quantity
- 48,180 bottles
- Company
- Bristol-myers Squibb Company, New Brunswick, NJ
- Distribution
- Nationwide in the US
- Initiated
- June 5, 2017 · Voluntary: Firm initiated
- Classified
- July 11, 2017
- Reported
- July 19, 2017
- Ended
- March 15, 2022
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Eliquis
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.